Meeting
2014 ASCO Annual Meeting
Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among U.S. veterans.
Authors
Jessica K Paulus
Tufts Clinical and Translational Science Institute, Boston, MA
Jessica K Paulus , Furha Iram Cossor , Christina D. Williams , Robert E. Martell , Michael J. Kelley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3535)
DOI
10.1200/jco.2014.32.15_suppl.3535
Abstract #
3535
Poster Bd #
24
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Validation of the survival benefit from metformin use in patients with type 2 diabetes and colorectal cancer.
First Author: Ibrahim Sahin
Poster
2024 ASCO Genitourinary Cancers Symposium
Cardiovascular medications and overall survival in metastatic hormone-sensitive prostate cancer.
First Author: Kara Ingram
Poster
2021 Genitourinary Cancers Symposium
A multicenter retrospective analysis examining the effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with prostate cancer.
First Author: Kelsey Pan
Poster
2016 ASCO Annual Meeting
Metabolic Characteristics of Esophageal Carcinoma in a Veteran Population.
First Author: Theresa Ratajczak